An initiative to prevent catheter-associated urinary tract infections provided the nursing staff with the best evidence for the care of the oncology patient with an indwelling urinary catheter, found research presented at the ONS 38th Annual Congress.
A neurological assessment guide has helped nurses to assess and document the use of high-dose cytarabine, according to research presented at the ONS 38th Annual Congress.
Oral electrolyte replacement is as effective as intravenous replacement in the adult oncology population, research presented at the ONS 38th Annual Congress has shown.
Preventative MuGard, a mucoadhesive oral protectant, reduces oral mucositis and weight loss, lessening the need for narcotic use in patients undergoing head and neck radiation therapy, found research presented at the ONS 38th Annual Congress.
An Oral Chemotherapy Nursing Practice Protocol increases documentation of patient education, follow-up calls and early symptom assessment, and adherence monitoring, found research presented at the ONS 38th Annual Congress.
An intervention that studied areas of a hospital that were contaminated helped to reduce the number of bacterial colonies on that floor, hopefully reducing the number of nosocomial infections, according to research presented at the ONS 38th Annual Congress.
Topical 1% sildenafil cream is well-tolerated, feasible to administer, and may help mitigate hand-foot syndrome, found research presented at the 38th ONS Annual Congress.
A neurologic assessment tool resulted in holding the dose of cytosine arabinoside for three separate patients, with no significant neurologic, cerebellar toxicity observed, found research presented at the ONS 38th Annual Congress.
“4MAT” education can help individualize and optimize patient use of an evidence-based skin care protocol based on the ONS Putting Evidence into Practice guidelines for radiation dermatitis, found research presented at the ONS 38th Annual Congress.
High-fidelity simulation as a teaching modality for a chemotherapy administration practicum is safe and effective, readily accepted, and helps bridge the transition to the clinical environment, found research presented at the 38th ONS Annual Congress.
